市場調查報告書

骨移植及替代骨移植片的全球市場的預測

Global Bone Grafts and Substitute Market Forecast 2018-2026

出版商 Inkwood Research 商品編碼 574465
出版日期 內容資訊 英文 143 Pages
商品交期: 2-3個工作天內
價格
Back to Top
骨移植及替代骨移植片的全球市場的預測 Global Bone Grafts and Substitute Market Forecast 2018-2026
出版日期: 2018年10月08日內容資訊: 英文 143 Pages
簡介

本報告提供骨移植及替代骨移植片的全球市場調查,市場概要,類型、應用領域、採取/固定各設備的市場趨勢,市場規模的預測(今後9年份),市場成長的各種影響要素,競爭情形,主要企業的簡介等系統性資訊。

第1章 調查範圍

第2章 調查手法

第3章 摘要整理

  • 市場摘要
  • 主要調查結果

第4章 市場決策要素

  • 促進因素
  • 阻礙因素
  • 市場機會
  • 課題

第5章 市場區隔

  • 各類型
    • 自體移植片
    • 異體移植片
    • 合成移植片
  • 各應用領域
    • 脊椎融合
    • 長骨
    • 腳、腳踝
    • 顱顏面
    • 關節重建
    • 牙科用移植片
  • 採取、固定設備
    • RIA系統
    • 移植片保持者
    • 濃厚血小板血漿(PC)系統
    • 穿孔器附件
    • 骨髓穿刺系統
    • 其他

第6章 市場分析

  • 波特的五力分析
  • 主要企業分析
  • 主要的購買標準

第7章 地區分析

  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 西班牙
    • 其他
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 其他
  • 其他地區
    • 南美
    • 中東、非洲

第8章 企業簡介

  • 競爭情形
    • 市場佔有率分析
    • 各地區的投資機會
    • 新的市場機會
    • 主要策略
  • ALLOSOURCE, INC.
  • BAXTER INTERNATIONAL INC.
  • DEPUY SYNTHES, INC
  • INTEGRA LIFESCIENCES CORP
  • MATHYS EUROPEAN ORTHOPEDIC
  • MEDTRONIC, INC.
  • NUVASIVE INC.
  • ORTHOFIX HOLDINGS, INC.
  • SIGMAGRAFT
  • SMITH AND NEPHEW PLC
  • STRYKER CORPORATION
  • ZIMMER BIOMET HOLDINGS INC
  • WRIGHT MEDICAL GROUP N.V.
  • XTANT MEDICAL HOLDINGS, INC.

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: 10932

KEY FINDINGS

The global bone graft and substitute market is projected to increase between the forecast years of 2018-2026 at a CAGR of 5.25%. Factors like high demand for orthopaedic procedures, technological advancements and unhealthy lifestyle choices leading to a rise in degenerative joint diseases are boosting the market growth.

MARKET INSIGHTS

The global bone graft and substitute market is segmented on the basis of applications, types, and harvesting and fixation devices. The market finds its application in treatments involving long bone, spinal fusion, craniomaxillofacial, foot and ankle, dental, and joint reconstruction. The bone graft and substitute types include autografts, allografts, and synthetics and additives. The harvesting and fixation devices are further sub-divided into implant holder, synthes RIA, platelet concentrate system, bone marrow aspirate concentrate systems, trephine attachment tool, and other harvest devices.

REGIONAL INSIGHTS

The global bone graft and substitutes market is regionally segmented into North America, Asia-Pacific, Europe and Rest of World. The Asia-Pacific market is anticipated to be the fastest-growing market, driven by rising incidences of osteoporosis and osteoarthritis and a growing number of hip and knee replacement surgeries. However, the North American region is expected to lead the global bone graft and substitute market by the end of the forecast period on account of the high incidences of bone fractures requiring bone grafting treatment.

COMPETITIVE INSIGHTS

Some of the competing companies in the market include Allosource Inc, Baxter International Inc, Depuy Synthes Inc, Integra Lifesciences Corp, Medtronic, Nuvasive Inc, Orthofix Holdings Inc, Sigmagraft, Smith And Nephew Plc, Stryker Corporation, Zimmer Biomet Holdings Inc, Wright Medical Group N.V and Xtant Medical Holdings Inc.

Table of Contents

1. RESEARCH SCOPE

  • 1.1. STUDY GOALS
  • 1.2. SCOPE OF THE MARKET STUDY
  • 1.3. WHO WILL FIND THIS REPORT USEFUL?
  • 1.4. STUDY AND FORECASTING YEARS

2. RESEARCH METHODOLOGY

  • 2.1. SOURCES OF DATA
    • 2.1.1. SECONDARY DATA
    • 2.1.2. PRIMARY DATA
    • 2.1.3. TOP DOWN APPROACH
  • 2.2. BOTTOM-UP APPROACH
  • 2.3. DATA TRIANGULATION

3. EXECUTIVE SUMMARY

  • 3.1. MARKET SUMMARY
  • 3.2. KEY FINDINGS
    • 3.2.1. SPINAL FUSIONS TO LEAD THE APPLICATION SEGMENT
    • 3.2.2. ASIA PACIFIC IS GROWING SIGNIFICANTLY
    • 3.2.3. ALLOGRAFT DOMINATES THE GLOBAL BONE GRAFT AND SUBSTITUTE MARKET

4. MARKET DETERMINANTS

  • 4.1. MARKET DRIVERS
    • 4.1.1. INCREASE IN TREATMENTS AND SURGERIES INVOLVING MUSCULOSKELETAL DISORDERS
    • 4.1.2. AGEING OF POPULATION IN KEY COUNTRIES
    • 4.1.3. INCREASING SOPHISTICATION OF BIOCOMPATIBLE SYNTHETIC BONE GRAFTS
    • 4.1.4. TECHNOLOGICAL ADVANCEMENTS
    • 4.1.5. UNHEALTHY LIFESTYLE CHOICES LEADING TO A RISE IN DEGENERATIVE JOINT DISEASES
    • 4.1.6. RISE IN SPINAL FUSION AND JOINT RECONSTRUCTION
    • 4.1.7. INCREASE IN DEMAND FOR ORTHOPEDIC PROCEDURE
  • 4.2. MARKET RESTRAINTS
    • 4.2.1. INCREMENTAL RISE IN THE COST OF SURGERIES
    • 4.2.2. ETHICAL ISSUES ASSOCIATED WITH BONE GRAFTING PROCEDURES
    • 4.2.3. THE STRINGENT REGULATORY APPROVAL PROCESS
  • 4.3. MARKET OPPORTUNITIES
    • 4.3.1. RESEARCH AND INVESTMENT IN BIOENGINEERING LEADING TO THE DEVELOPMENT OF HYBRID MATERIAL FOR BONE GRAFTING
    • 4.3.2. RISE IN REIMBURSEMENT FOR SURGERIES IN DEVELOPED NATIONS
  • 4.4. MARKET CHALLENGES
    • 4.4.1. SURGICAL RISK RELATED TO REJECTION DUE TO IMMUNE RESPONSE
    • 4.4.2. LIMITED SUPPLY AND HIGH DONOR SITE MORBIDITY RATE.FOR AUTOGRAPHS
    • 4.4.3. INCREASED SCRUTINY OF STEM CELL-DERIVED PRODUCTS
    • 4.4.4. OFF-LABEL USE OF BONE GRAFT MATERIAL
    • 4.4.5. HIGH COST OF BONE GRAFTING SURGERIES

5. MARKET SEGMENTATION

  • 5.1. MARKET BY TYPE 2018-2026
    • 5.1.1. ALLOGRAFT
    • 5.1.2. AUTOGRAFTS
    • 5.1.3. SYNTHETICS AND ADDITIVES
  • 5.2. MARKET BY APPLICATION 2018-2026
    • 5.2.1. SPINAL FUSION
    • 5.2.2. LONG BONE
    • 5.2.3. FOOT AND ANKLE
    • 5.2.4. CRANIOMAXILOFACIAL
    • 5.2.5. JOINT RECONSTRUCTION
    • 5.2.6. DENTAL BONE GRAFT
  • 5.3. MARKET BY HARVESTING AND FIXATION DEVICES 2018-2026
    • 5.3.1. SYNTHES RIA MARKET
    • 5.3.2. IMPLANT HOLDER
    • 5.3.3. PLATELET CONCENTRATE SYSTEM
    • 5.3.4. TREPHINE ATTACHMENT TOOL
    • 5.3.5. BONE MARROW ASPIRATE CONCENTRATED SYSTEM
    • 5.3.6. OTHER HARVEST DEVICES

6. KEY ANALYTICS

  • 6.1. PORTER'S FIVE FORCE ANALYSIS
    • 6.1.1. THREAT OF NEW ENTRANTS
    • 6.1.2. THREAT OF SUBSTITUTE PRODUCTS
    • 6.1.3. BARGAINING POWER OF BUYER
    • 6.1.4. BARGAINING POWER OF SUPPLIER
    • 6.1.5. INTENSITY OF COMPETITIVE RIVALRY
  • 6.2. KEY COMPANY ANALYSIS
  • 6.3. KEY BUYING CRITERIA
  • 6.4. OPPORTUNITY MATRIX

7. GEOGRAPHICAL ANALYSIS

  • 7.1. NORTH AMERICA
    • 7.1.1. THE UNITED STATES
    • 7.1.2. CANADA
  • 7.2. EUROPE
    • 7.2.1. THE UNITED KINGDOM
    • 7.2.2. FRANCE
    • 7.2.3. GERMANY
    • 7.2.4. SPAIN
    • 7.2.5. REST OF EUROPE
  • 7.3. ASIA-PACIFIC
    • 7.3.1. CHINA
    • 7.3.2. INDIA
    • 7.3.3. JAPAN
    • 7.3.4. AUSTRALIA
    • 7.3.5. SOUTH KOREA
    • 7.3.6. REST OF ASIA-PACIFIC
  • 7.4. REST OF WORLD (ROW)
    • 7.4.1. LATIN AMERICA
    • 7.4.2. MIDDLE EAST & AFRICA

8. COMPANY PROFILE

  • 8.1. COMPETITIVE ANALYSIS
    • 8.1.1. MARKET SHARE ANALYSIS
  • 8.2. ALLOSOURCE INC
    • 8.2.1. MARKET OVERVIEW
    • 8.2.2. PRODUCT PORTFOLIO
    • 8.2.3. SCOT ANALYSIS
    • 8.2.4. STRATEGIC INITIATIVES
  • 8.3. BAXTER INTERNATIONAL INC
    • 8.3.1. MARKET OVERVIEW
    • 8.3.2. PRODUCT PORTFOLIO
    • 8.3.3. SCOT ANALYSIS
    • 8.3.4. STRATEGIC INITIATIVES
  • 8.4. DEPUY SYNTHES INC
    • 8.4.1. MARKET OVERVIEW
    • 8.4.2. PRODUCT PORTFOLIO
    • 8.4.3. SCOT ANALYSIS
    • 8.4.4. STRATEGIC INITIATIVES
  • 8.5. INTEGRA LIFESCIENCES CORP
    • 8.5.1. MARKET OVERVIEW
    • 8.5.2. PRODUCT PORTFOLIO
    • 8.5.3. SCOT ANALYSIS
    • 8.5.4. STRATEGIC INITIATIVES
  • 8.6. MEDTRONIC
  • 8.7. INC.
    • 8.7.1. MARKET OVERVIEW
    • 8.7.2. PRODUCT PORTFOLIO
    • 8.7.3. SCOT ANALYSIS
    • 8.7.4. STRATEGIC INITIATIVES
  • 8.8. NUVASIVE INC.
    • 8.8.1. MARKET OVERVIEW
    • 8.8.2. PRODUCT PORTFOLIO
    • 8.8.3. SCOT ANALYSIS
    • 8.8.4. STRATEGIC INITIATIVES
  • 8.9. ORTHOFIX HOLDINGS, INC.
    • 8.9.1. MARKET OVERVIEW
    • 8.9.2. PRODUCT PORTFOLIO
    • 8.9.3. SCOT ANALYSIS
    • 8.9.4. STRATEGIC INITIATIVE
  • 8.10. SIGMAGRAFT
    • 8.10.1. MARKET OVERVIEW
    • 8.10.2. PRODUCT PORTFOLIO
    • 8.10.3. SCOT ANALYSIS
    • 8.10.4. STRATEGIC INITIATIVE
  • 8.11. SMITH AND NEPHEW PLC
    • 8.11.1. MARKET OVERVIEW
    • 8.11.2. PRODUCT PORTFOLIO
    • 8.11.3. SCOT ANALYSIS
    • 8.11.4. STRATEGIC INITIATIVE
  • 8.12. STRYKER CORPORATION
    • 8.12.1. MARKET OVERVIEW
    • 8.12.2. PRODUCT PORTFOLIO
    • 8.12.3. SCOT ANALYSIS
    • 8.12.4. STRATEGIC INITIATIVE
  • 8.13. ZIMMER BIOMET HOLDINGS INC
    • 8.13.1. MARKET OVERVIEW
    • 8.13.2. PRODUCT PORTFOLIO
    • 8.13.3. SCOT ANALYSIS
    • 8.13.4. STRATEGIC INITIATIVES
  • 8.14. WRIGHT MEDICAL GROUP N.V.
    • 8.14.1. MARKET OVERVIEW
    • 8.14.2. PRODUCT PORTFOLIO
    • 8.14.3. SCOT ANALYSIS
    • 8.14.4. STRATEGIC INITIATIVES
  • 8.15. XTANT MEDICAL HOLDINGS, INC.
    • 8.15.1. MARKET OVERVIEW
    • 8.15.2. PRODUCT PORTFOLIO
    • 8.15.3. SCOT ANALYSIS
    • 8.15.4. STRATEGIC INITIATIVES

TABLE LIST

  • TABLE 1 GLOBAL BONE GRAFTS AND SUBSTITUTE MARKET BY GEOGRAPHY 2018-2026 ( MILLION)
  • TABLE 2 GLOBAL BONE GRAFTS AND SUBSTITUTE MARKET BY TYPE 2018-2026 ( MILLION)
  • TABLE 3 GLOBAL BONE GRAFT AND SUBSTITUTE MARKET IN ALLOGRAFTS BY GEOGRAPHY 2018-2026 (MILLION)
  • TABLE 4 GLOBAL BONE GRAFT AND SUBSTITUTE MARKET IN AUTOGRAFTS BY GEOGRAPHY 2018-2026 ( MILLION)
  • TABLE 5 GLOBAL BONE GRAFTS SUBSTITUTE MARKET IN SYNTHETICS AND ADDITIVES MARKET BY GEOGRAPHY 2018-2026 (MILLION)
  • TABLE 6 GLOBAL BONE GRAFTS AND SUBSTITUTE MARKET BY APPLICATION 2018-2026 ( MILLION)
  • TABLE 7 GLOBAL BONE GRAFT AND SUBSTITUTE MARKET IN SPINAL BY GEOGRAPHY 2018-2026 ( MILLION)
  • TABLE 8 GLOBAL BONE GRAFT AND SUBSTITUTE MARKET IN LONG BONE BY GEOGRAPHY 2018-2026 (MILLION)
  • TABLE 9 GLOBAL BONE GRAFT AND SUBSTITUTE MARKET IN FOOT AND ANKLE BY GEOGRAPHY 2018-2026 ( MILLION)
  • TABLE 10 GLOBAL BONE GRAFT AND SUBSTITUTE MARKET IN CRANOMAXILOFACIAL BY GEOGRAPHY 2018-2026 ( MILLION)
  • TABLE 11 GLOBAL BONE GRAFT AND SUBSTITUTE MARKET IN JOINT RECONSTRUCTION BY GEOGRAPHY 2018-2026 ( MILLION)
  • TABLE 12 GLOBAL BONE GRAFT AND SUBSTITUTE MARKET IN DENTAL BONE GRAFT BY GEOGRAPHY 2018-2026 (MILLION)
  • TABLE 13 GLOBAL BONE GRAFTS AND SUBSTITUTE MARKET BY HARVESTING AND FIXATION DEVICES 2018-2026 ( MILLION)
  • TABLE 14 GLOBAL BONE GRAFT AND SUBSTITUTE MARKET IN SYNTHES RIABY GEOGRAPHY 2018-2026 (MILLION)
  • TABLE 15 GLOBAL BONE GRAFT AND SUBSTITUTE MARKET IN IMPLANT HOLDERBY GEOGRAPHY 2018-2026 (MILLION)
  • TABLE 16 GLOBAL BONE GRAFT AND SUBSTITUTE MARKET IN PLATELET CONCENTRATE SYSTEM BY GEOGRAPHY 2018-2026 (MILLION)
  • TABLE 17 GLOBAL BONE GRAFT AND SUBSTITUTE MARKET IN TREPHINE ATTACHMENT TOOL BY GEOGRAPHY 2018-2026 (MILLION)
  • TABLE 18 GLOBAL BONE GRAFT AND SUBSTITUTE MARKET IN BONE MARROW ASPIRATE CONCENTRATED SYSTEM BY GEOGRAPHY 2018-2026 (MILLION)
  • TABLE 19 GLOBAL BONE GRAFT AND SUBSTITUTE MARKET IN OTHER HARVESTING DEVICE BY GEOGRAPHY 2018-2026 (MILLION)
  • TABLE 20 NORTH AMERICA BONE GRAFT AND SUBSTITUTE MARKET BY COUNTRIES 2018-2026 ( MILLION)
  • TABLE 21 EUROPE BONE GRAFT AND SUBSTITUTE MARKET BY COUNTRIES 2018-2026 ( MILLION)
  • TABLE 22 ASIA-PACIFIC BONE GRAFT & SUBSTITUTE MARKET BY COUNTRIES 2018-2026 ( MILLION)
  • TABLE 23 REST OF WORLD BONE GRAFT AND SUBSTITUTE MARKET BY COUNTRIES 2018-2026 ( MILLION)

FIGURES LIST

  • FIGURE 1 GLOBAL BONE GRAFTS AND SUBSTITUTE MARKET 2018-2026 ( MILLION)
  • FIGURE 2 PERCENTAGE DISTRIBUTION OF POPULATION AGED ABOVE 65 YEARS FOR 2015 & 2050
  • FIGURE 3 DIABETES INCIDENCE IN THE TOP 10 COUNTRIES IN 2016 (MILLION)
  • FIGURE 4 THE UNITED STATES BONE GRAFT AND SUBSTITUTE 2018-2026 ( MILLION)
  • FIGURE 5 CANADA BONE GRAFT AND SUBSTITUTE 2018-2026 ( MILLION)
  • FIGURE 6 THE UNITED KINGDOM BONE GRAFT AND SUBSTITUTE MARKET 2018-2026 ( MILLION)
  • FIGURE 7 FRANCE BONE GRAFT AND SUBSTITUTE MARKET 2018-2026 ( MILLION)
  • FIGURE 8 GERMANY BONE GRAFT AND SUBSTITUTE MARKET 2018-2026 ( MILLION)
  • FIGURE 9 SPAIN BONE GRAFT AND SUBSTITUTE MARKET 2018-2026 ( MILLION)
  • FIGURE 10 REST OF EUROPE BONE GRAFT AND SUBSTITUTE MARKET 2018-2026 ( MILLION)
  • FIGURE 11 CHINA BONE GRAFT & SUBSTITUTE MARKET 2018-2026 ( MILLION)
  • FIGURE 12 INDIA BONE GRAFT & SUBSTITUTE MARKET 2018-2026 ( MILLION)
  • FIGURE 13 JAPAN BONE GRAFT & SUBSTITUTE MARKET 2018-2026 ( MILLION)
  • FIGURE 14 AUSTRALIA BONE GRAFT & SUBSTITUTE MARKET 2018-2026 ( MILLION)
  • FIGURE 15 SOUTH KOREA BONE GRAFT & SUBSTITUTE 2018-2026 ( MILLION)
  • FIGURE 16 REST OF ASIA-PACIFIC BONE GRAFT & SUBSTITUTE 2018-2026 ( MILLION)
  • FIGURE 17 LATIN AMERICA BONE GRAFT AND SUBSTITUTE MARKET 2018-2026 ( MILLION)
  • FIGURE 18 MIDDLE EAST & AFRICA BONE GRAFT AND SUBSTITUTE MARKET 2018-2026( MILLION)
  • FIGURE 19 GLOBAL BONE GRAFT & SUBSTITUTE MARKET SHARE OF COMPANIES 2017 (%)
Back to Top